AssetMark Inc’s Phibro Animal Health PAHC Stock Holding History

AssetMark Inc’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$188	Sell	6 -9	-60%	-$380	﹤0.01%	3429
2026 Q1	$830	Buy	15 +9	+150%	+$428	﹤0.01%	3076
2025 Q4	$224	Buy	+6	New	+$244	﹤0.01%	3239
2018 Q1	–	Sell	-7	Closed	–	–	1826
2017 Q4	$0	Buy	+7	New	+$249	﹤0.01%	2058
2017 Q1	–	Sell	-10	Closed	–	–	1389
2016 Q4	$0	Buy	+10	New	+$273	﹤0.01%	1347

Other funds holding PAHC

HAI

Hennessy Advisors Inc Novato, California $3.13B AUM 77.26% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

CCMINC

Cardinal Capital Management Inc (North Carolina) Raleigh, North Carolina $826M AUM 32.06% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

HSA

Hussman Strategic Advisors Ellicott City, Maryland $434M AUM 19.64% 1-Year Est. Return

SGAM

Smith Group Asset Management Dallas, Texas $2.46B AUM 57.16% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

AssetMark Inc's PAHC Position: Q2 2026 in Review

AssetMark Inc reduced its Phibro Animal Health (PAHC) stake by 60% in Q2 2026, selling an estimated $380 and leaving 6 shares worth $188. The position accounts for ﹤0.01% of the portfolio, ranked #3429.

AssetMark Inc first reported a position in PAHC in Q4 2016 and has held it in 5 quarters since. The position peaked at $830 in Q1 2026. 55 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

AssetMark Inc held 6 shares of Phibro Animal Health worth $188 as of Q2 2026.
AssetMark Inc sold 9 Phibro Animal Health shares in Q2 2026, an estimated $380.
Phibro Animal Health made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #3429 holding.
AssetMark Inc first reported a position in Phibro Animal Health in Q4 2016 and has held it in 5 quarters since.
AssetMark Inc's Phibro Animal Health position peaked at $830 in Q1 2026.
55 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.